These results demonstrated that ANGPTL1 was a direct target gene of miR-92-1 and suggested that the miR-92-1-repressing anti-angiogenic protein ANGPTL1 might contribute to AGO2-mediated myeloma angiogenesis. The gene discussed is AGO2; the disease is plasma cell myeloma.